An outbreak of vancomycin-resistant Enterococcus faecium in an acute care pediatric hospital: Lessons from environmental screening and a case-control study

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 19, Issue 3, 2008, Pages 233-236

  Drews, Steven J ^a   Richardson, Susan E ^a   Wray, Rick ^a   Freeman, Renee ^a   Goldman, Carol ^a   Streitenberger, Laurie ^a   Stevens, Derek ^a   Goia, Cristina ^a   Kovach, Danuta ^a   Brophy, Jason ^a   Matlow, Anne G ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cephalosporins; Outbreak; Pediatrics; Risk factor; VRE

Indexed keywords

CEPHALOSPORIN; COTRIMOXAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; HUMAN; INFECTION RISK; MULTIVARIATE ANALYSIS; PEDIATRIC WARD; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RECREATION; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 49149110115     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/727062     Document Type: Article

References (17)

1. Gearhart M, Martin J, Rudich S, et al. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: A matched control study. Clin Transplant 2005;19:711-6.
2. McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study. Clin Infect Dis 2006;42:195-203.
3. Hwang YS, Brinton BG, Leonard RB, Blue SR, Woods ML, Carroll KC. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium in a low prevalence university hospital. J Investig Med 1998;46:435-43.
4. Gray JW, George RH. Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 2000;45:11-8.
5. Nourse C, Murphy H, Byrne C, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: Risk factors for colonisation. Eur J Pediatr 1998;157:20-7. (Erratum in 1998;157:405).
6. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166:1945-51.
7. National Committee for Clinical Laboratory Standards. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically - Approved standard M7-A6. Wayne: NCCLS, 2003.
8. Drews SJ, Johnson G, Gharabaghi F, et al. A 24-hour screening protocol for identification of vancomycin-resistant Enterococcus faecium. J Clin Microbiol 2006;44:1578-80.
9. Division of Nosocomial and Occupational Infectious Diseases, Bureau of Infectious Diseases, Laboratory Centre for Disease Control, Health Canada; VRE Working Group, Canadian Hospital Epidemiology Committee. Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada. Can Commun Dis Rep 1997;23(Suppl 8):i-iv,1-16,i-iv,1-19.
10. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
11. Borgmann S, Niklas DM, Klare I, et al. Two episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unit. Int J Hyg Environ Health 2004;207:386-9.
12. Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999;88:651-4.
13. Armeanu E, Bonten MJ. Control of vancomycin-resistant enterococci: One size fits all? Clin Infect Dis 2005;41:210-6.
14. Stiefel U, Paterson DL, Pule NJ, Gordon SM, Aran DC, Donskey CJ. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers. Infect Control Hosp Epidemiol 2004;25:380-3.
15. Lankford MG, Collins S, Youngberg L, Rooney DM, Warren JR, Noskin GA. Assessment of materials commonly utilized in health care: Implications for bacterial survival and transmission. Am J Infect Control 2006;34:258-63.
16. Singh N, Léger MM, Campbell J, Short B, Campos JM. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2005;26:646-9.
17. Malik RK, Montecalvo MA, Reale MR, et al. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit. Pediatr Infect Dis J 1999;18:352-6.